Projected Income Statement: Eurazeo SE

Forecast Balance Sheet: Eurazeo SE

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
Net Debt 1 3,195 2,964 4,416 823 1,343 1,436 1,388 843
Change - -7.23% 48.99% -81.36% 63.18% 6.92% -3.34% -39.27%
Announcement Date 11/03/21 25/03/22 06/04/23 07/03/24 28/03/25 - - -
1EUR in Million
Estimates

Cash Flow Forecast: Eurazeo SE

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
CAPEX 1 170.8 259.8 444.7 12.57 18.18 - - -
Change - 52.05% 71.19% -97.17% 44.64% -100% - -
Free Cash Flow (FCF) 1 130.4 213.7 -190.6 -24.18 50.7 1,127 1,427 1,538
Change - 63.86% -189.17% 87.31% 309.66% 2,122.56% 26.63% 7.77%
Announcement Date 11/03/21 25/03/22 06/04/23 07/03/24 28/03/25 - - -
1EUR in Million
Estimates

Forecast Financial Ratios: Eurazeo SE

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027

Profitability

        
EBITDA Margin (%) 14.57% 16.29% 14.29% 30.43% -82.19% -12.51% 79.53% 92.57%
EBIT Margin (%) 7.23% 9.9% 9.65% 25.85% -86.44% -16.14% 65.05% 78.09%
EBT Margin (%) -7.34% 44.71% 12.35% 540.51% -108.51% -15.74% 54.8% 74.28%
Net margin (%) -4.37% 35.08% 12.82% 530.7% -112.13% -24.59% 45.37% 60.94%
FCF margin (%) 3.56% 4.76% -4.11% -7.04% 13.23% 266.4% 180.3% 163.4%
FCF / Net Income (%) -81.62% 13.56% -32.05% -1.33% -11.8% -1,083.41% 397.42% 268.12%

Profitability

        
ROA - - - - - - - -
ROE -3.31% 29.09% 9.41% 25.03% -5.6% 6.55% 8.65% 11.1%

Financial Health

        
Leverage (Debt/EBITDA) 5.99x 4.05x 6.66x 7.87x -4.26x -27.13x 2.2x 0.97x
Debt / Free cash flow 24.5x 13.87x -23.17x -34.03x 26.49x 1.27x 0.97x 0.55x

Capital Intensity

        
CAPEX / Current Assets (%) 4.67% 5.78% 9.58% 3.66% 4.74% - - -
CAPEX / EBITDA (%) 32.04% 35.48% 67.05% 12.02% -5.77% - - -
CAPEX / FCF (%) 130.98% 121.54% -233.33% -51.99% 35.87% - - -

Items per share

        
Cash flow per share 1 4.23 4.351 3.483 -0.1626 0.9482 7.367 10.89 12.02
Change - 2.85% -19.95% -104.67% 683.11% 676.91% 47.85% 10.39%
Dividend per Share 1 1.5 1.75 2.2 2.42 2.65 2.894 3.141 3.408
Change - 16.67% 25.71% 10% 9.5% 9.21% 8.53% 8.49%
Book Value Per Share 1 58.99 80.34 85.56 110.1 102.5 95.41 99.2 107.8
Change - 36.2% 6.5% 28.65% -6.86% -6.94% 3.98% 8.63%
EPS 1 -2.24 21.75 8.22 25.56 -5.95 -0.78 6.97 12.79
Change - 1,070.98% -62.21% 210.95% -123.28% 86.89% 993.59% 83.5%
Nbr of stocks (in thousands) 76,163 76,494 76,744 74,736 72,219 62,236 62,236 62,236
Announcement Date 11/03/21 25/03/22 06/04/23 07/03/24 28/03/25 - - -
1EUR
Estimates
2025 *2026 *
P/E ratio -64.1x 7.17x
PBR 0.52x 0.5x
EV / Sales 10.8x 5.69x
Yield 5.79% 6.28%

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
50.00EUR
Average target price
74.00EUR
Spread / Average Target
+48.00%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. RF Stock
  4. Financials Eurazeo SE